This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

    More

    Page   1/2   
  • Guideposts Dementia Information Prescription
    Post-diagnostic support is key to effective care for people with dementia and their carers. Deloitte Centre for Health Solutions evaluates one approach, Dementia Information Prescription (DIP), developed by the Guideposts Trust.
  • Routes from Diagnosis
    Macmillan’s Routes from Diagnosis research programme, in partnership with Monitor Deloitte, and Public Health England’s National Cancer Intelligence Network provides the in most detailed map of cancer survivorship yet. Read the report.
  • Real World Evidence
    Learn about how healthcare data presents a unique opportunity to develop insights which can help transform patient care.
  • Good Evidence Practice
    Building stakeholder trust in the use of health data to generate Real World Evidence for the benefit of patients.
  • Measuring the return from Pharmaceutical innovation 2013
    This Deloitte report is the fourth in an annual series exploring the pharmaceutical industry’s performance in generating a return from its investment in new product innovation.
  • Working differently to provide early diagnosis
    A UK Deloitte Centre for Health Solutions report which examines how healthcare commissioners and providers can work differently with the diagnostic industry and other providers to increase early diagnosis.
  • Telecare and Telehealth
    'Telecare and Telehealth - A game changer for health and social care’ looks at the role that telecare and telehealth can play in helping to transform health and social care by enabling commissioners and providers to respond effectively to rising demand for health and social care services.
  • 2011 Survey of Health Care Consumers in UK
    This is the second consecutive year Deloitte has published research on consumers' behaviors, attitudes and unmet needs based on their personal experiences and observations of the UK health care systems. View all country reports.
  • Measuring the return from innovation
    Last year Deloitte and Thomson Reuters conducted an analysis into value measurement at the "whole R&D business" level using Internal Rate of Return (IRR). This year, we have extended our analysis, looking at the same cohort of companies one year on.
  • Impact of European Austerity on Pharmaceutical policy and pricing
    A UK Deloitte Centre for Health solutions report that looks to understand the current European pharmaceutical market, the mechanisms for reducing pharmaceutical spending, the future of the pharmaceutical landscape, and the actions the pharmaceutical industry needs to take to survive current austerity.
  • Page   1/2   
Follow:

Get in touch

More on Deloitte